Clinical Trial Update: Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed whether adding bicalutamide and goserelin to radiation therapy improves treatment outcomes for prostate cancer compared with radiation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Casodex (bicalutamide)
• Zoladex (goserelin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED